.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Harvard Business School
Merck
Citi
Federal Trade Commission
Cerilliant
Fish and Richardson
McKesson
Fuji

Generated: November 19, 2017

DrugPatentWatch Database Preview

PHENTERMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Phentermine Hydrochloride, and when can generic versions of Phentermine Hydrochloride launch?

Phentermine Hydrochloride is a drug marketed by Vitarine, Able, Usl Pharma, Sandoz Inc, Tg United Labs, Sandoz, Ken Lifescience, Abc Holding, Teva, Invagen Pharms, Aurolife Pharma Llc, Lannett, Sun Pharm Inds, Camall, Elite Labs Inc, Ivax Pharms, Upsher-smith Labs, Kvk Tech Inc, Watson Labs, Polygen Pharms, Duramed Pharms Barr, Elite Labs, Ingenus Pharms Nj, Mikah Pharma, Lannett Holdings Inc, Zydus Pharms Usa Inc, Barr, Kvk Tech, Actavis Elizabeth, Prinston Inc, Tg United Inc, and Sun Pharm Inds Inc. and is included in eighty-seven NDAs.

The generic ingredient in PHENTERMINE HYDROCHLORIDE is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL204663-003Jun 28, 2017RXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL040527-001Oct 23, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL087223-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Kvk Tech
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL040887-001Apr 24, 2008AARXNoNo► Subscribe► Subscribe► Subscribe
Kvk Tech Inc
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
TABLET;ORAL203436-001Mar 17, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
Ingenus Pharms Nj
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
TABLET;ORAL091451-001Sep 21, 2012AARXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL088430-001Mar 27, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
TABLET;ORAL085739-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
CAPSULE;ORAL202846-001Feb 5, 2014AARXNoNo► Subscribe► Subscribe► Subscribe
Tg United Labs
PHENTERMINE HYDROCHLORIDE
phentermine hydrochloride
TABLET;ORAL088596-001Apr 4, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Boehringer Ingelheim
Julphar
Fuji
Teva
Express Scripts
Healthtrust
US Department of Justice
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot